Feature story

UNAIDS commends commitment by the Bill & Melinda Gates Foundation to advancing vaccine research and development

Geneva, 29 January 2010—UNAIDS strongly applauds today’s announcement by the Bill & Melinda Gates Foundation to invest USD 10 billion into research and development of vaccines over the next 10 years.

The announcement, made at the World Economic Forum in Davos, is a welcome step forward in commitment to vaccine research, however large gaps in funding for the research and development of vaccines still remain.

“The best hope for ending the AIDS epidemic lies in a developing a vaccine,” said Michel Sidibé, Executive Director of UNAIDS. “A vaccine for HIV would save millions of lives and I call on both governments and the private sector to follow this example and scale-up their commitment to this important area of work in health and development.”

The long term response to the AIDS epidemic depends on progress in HIV prevention research and continued funding for scientific research and development. A vaccine for HIV still remains many years away and UNAIDS will continue to advocate to advance the research and development agenda at national, regional and global levels to bring the quest for a vaccine closer.

Related feature stories

Press centre:

Download printable version (pdf, 20.1 Kb.)


UNAIDS: Sophie Barton-Knott
Tel. +41 22 791 1697
E-mail: bartonknotts@unaids.org